VAXELIS 20 ug/.5mL
diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine · INJECTION, SUSPENSION · MSP Vaccine Company
Vaxelis is a combination vaccine that protects against six diseases: diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b, and hepatitis B. It is given as an injection and is commonly used for infant and childhood immunization.
Key Facts
- Brand Name
- VAXELIS
- Generic Name
- diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine
- NDC Code (Product)
63361-243- Manufacturer
- MSP Vaccine Company
- Strength
- 20 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125563
- Marketing Start
- 12/21/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is VAXELIS used for?
Vaxelis is a combination vaccine that protects against six diseases: diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b, and hepatitis B. It is given as an injection and is commonly used for infant and childhood immunization.
Is VAXELIS a controlled substance?
VAXELIS is not classified as a controlled substance by the DEA.
What is the generic name for VAXELIS?
The generic name for VAXELIS is diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine. There are no other listed brand versions of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine.
What is the NDC code for VAXELIS 20 ug/.5mL?
The NDC (National Drug Code) for VAXELIS 20 ug/.5mL is 63361-243, listed by MSP Vaccine Company.
Other VAXELIS Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)